BCL2L11 and non-small cell lung carcinoma: Several clinical observations found that EGFR-mutant NSCLC patients carrying the 2903 bp deletion had shorter PFS and OS and were less responsive to EGFR-TKIs than those who did not have the deletion, suggesting that BIM deletion polymorphism may be an independent predictor for prognosis [18–20].